Saptalis Pharmaceuticals, LLC

FDA inspection history in Hauppauge, New York, 2018 to 2026

3
Form 483s

Every document, by year

  • Form 483

2018: one Form 483; 2023: one Form 483; 2026: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2018One Form 483, at Hauppauge, New York.
  2. 2023One Form 483, at Hauppauge, New York.
  3. 2023The longest 483 on file: 4 observations over 4 pages at Hauppauge, New York.
  4. 2026One Form 483, at Hauppauge, New York.

Cited most

Across all Saptalis Pharmaceuticals observations on file

The complete Saptalis Pharmaceuticals file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2026-03-06483 Form 483$99
2023-03-17483 Form 483$99
2018-10-30483 Form 483$99

FEI number 3012152381 · most recent document Mar 6, 2026

About Saptalis Pharmaceuticals, LLC

How many FDA Form 483s has Saptalis Pharmaceuticals, LLC received?

FDA Intel has 3 Form 483s on file for Saptalis Pharmaceuticals, LLC; the most recent is dated Mar 6, 2026.

When was Saptalis Pharmaceuticals, LLC last inspected by FDA?

The most recent FDA inspection document on file for Saptalis Pharmaceuticals, LLC is a Form 483 dated Mar 6, 2026, for the site in Hauppauge, New York.

What did FDA cite at Saptalis Pharmaceuticals, LLC?

The regulations cited most in the observations on file for Saptalis Pharmaceuticals, LLC are 21 CFR 211.80 (General requirements), 2 times; 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.165 (Testing and release for distribution), 1 time.